Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Jeffrey Borman, Integrichain, Inc.
Advertisement
Articles by Jeffrey Borman, Integrichain, Inc.
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
Published: April 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Trump’s New Healthcare Roadmap, FDA Vaccine Warnings, and BPD to Lead The Agency Network
2
Amazon Pharmacy Adds FDA-Approved Wegovy Pill, the First Oral GLP-1 for Weight Loss
3
AbbVie Joins TrumpRx in Exchange for Tariff Relief and Pricing Flexibility
4
Evaluate’s 2026 Pharma Forecast Signals Cautious Recovery, Rising M&A, and GLP-1 Market Shifts
5